European Archives - Page 990 of 991 - European Medical Journal

Retrograde Approach for Chronic Total Occlusions: The Importance of Experience and Proctorship

Recanalisation of chronic total occlusions has remained suboptimal in the field of percutaneous coronary intervention (PCI). Hopes for a better outcome…

Multivariate Analysis and Outcomes in Percutaneous Coronary Intervention; from Statistics to Cath Lab

High quality randomised clinical trials (RCTs) and meta-analysis represent the highest levels of evidence, but in everyday clinical practice…

Update on Drug-Eluting Balloons for Percutaneous Coronary Interventions

Restenosis prevention continues to be a challenge to the interventional cardiologist. The introduction of stents has virtually eliminated the problems of…

Pacemaker-Dependence After Transcatheter Aortic Valve Implantation

Transcatheter aortic valve implantation (TAVI) has emerged as an alternative for multimorbid patients not suitable for open heart surgery. The vicinity…

EMJ Hepatology 1.1 2013

Hello, and welcome to the first edition of European Medical Journal – Hepatology, in which we aim to provide all specialists with a high quality…

EMJ

EMJ Urology 2013

A comprehensive review of the 28th EAU annual congress held in Milan, Italy

The Role of Environmental Factors in Digestive Cancer

The risk of digestive cancer in each country is analyzed in cancer registries for Incidence and Mortality. Survival is estimated from registries with a…

Vaginal pH Self-Screening as a KISS Regimen in Prevention of Early Preterm Birth

Self-measurement of vaginal pH is an established screening procedure for prevention of premature birth due to abnormal vaginal flora and bacterial…

Risk of Ovarian Malignancy (ROMATM) – Determining the Likelihood of Malignancy in Women with Pelvic Mass

Ovarian cancer is a malignancy with poor prognosis and is still the leading cause of death from gynecological malignancies worldwide.

Primary Screening for Human Papillomavirus in Cervical Cancer Prevention

Acquisition of a high risk Human Papillomavirus (hr HPV) infection is a necessary step in the pathogenesis of cervical cancer.